CRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Salesforce Inc (CRM) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive sentiment from Congress trading, and its partnership with the U.S. Department of Labor provide long-term growth catalysts. Despite short-term technical weakness, the stock's fundamentals and positive analyst outlook make it a solid investment opportunity.
The technical indicators show a bearish trend. The MACD is negatively expanding, RSI is neutral at 36.031, and moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). Key support is at 182.474, and resistance is at 199.932. Short-term price movement may remain weak.
Congress members made 4 purchase transactions totaling $1.5M-$5.0M, indicating strong confidence in the stock.
Salesforce's partnership with the U.S. Department of Labor to modernize the National Contact Center using AI technologies is a significant growth driver.
Financial performance in Q4 2026 shows strong revenue (+12.09% YoY), net income (+13.76% YoY), and EPS (+17.61% YoY) growth.
Analysts have an average price target of $263.57, reflecting a significant upside from the current price.
Technical indicators suggest short-term bearish trends.
Gross margin declined slightly (-0.26% YoY), which could indicate cost pressures.
Analyst price targets have been lowered recently, reflecting sector-wide valuation compression.
In Q4 2026, Salesforce reported revenue of $11.2B (+12.09% YoY), net income of $1.94B (+13.76% YoY), and EPS of $2.07 (+17.61% YoY). However, gross margin slightly declined to 77.61% (-0.26% YoY). Overall, the company demonstrated strong growth despite minor margin pressure.
Analyst sentiment is mixed but leans positive. Recent price targets range from $200 to $325, with an average target of $263.57. Analysts highlight Salesforce's AI-driven Agentforce as a key growth driver but note weaker organic growth in the near term.
